194 related articles for article (PubMed ID: 34040895)
1. The relationship between PLOD1 expression level and glioma prognosis investigated using public databases.
Tian L; Zhou H; Wang G; Wang WY; Li Y; Xue X
PeerJ; 2021; 9():e11422. PubMed ID: 34040895
[TBL] [Abstract][Full Text] [Related]
2. ANXA1: An Important Independent Prognostic Factor and Molecular Target in Glioma.
Zhang D; Wang W; Zhou H; Su L; Han X; Zhang X; Han W; Wang Y; Xue X
Front Genet; 2022; 13():851505. PubMed ID: 35711921
[No Abstract] [Full Text] [Related]
3. MELK is a prognostic biomarker and correlated with immune infiltration in glioma.
Yang H; Zhou H; Wang G; Tian L; Li H; Zhang Y; Xue X
Front Neurol; 2022; 13():977180. PubMed ID: 36353126
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of the Expression, Prognosis, and Biological Significance of PLOD Family in Bladder Cancer.
Chen R; Jiang M; Hu B; Fu B; Sun T
Int J Gen Med; 2023; 16():707-722. PubMed ID: 36872941
[TBL] [Abstract][Full Text] [Related]
5. Expression and Prognostic Role of PLOD1 in Malignant Glioma.
Wang H; Luo W; Dai L
Onco Targets Ther; 2020; 13():13285-13297. PubMed ID: 33402837
[TBL] [Abstract][Full Text] [Related]
6. Clinical Prognostic Value of the
Meng Y; Sun J; Zhang G; Yu T; Piao H
Front Mol Biosci; 2021; 8():770729. PubMed ID: 35265665
[TBL] [Abstract][Full Text] [Related]
7. Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer.
Zhang J; Tian Y; Mo S; Fu X
Int J Gen Med; 2022; 15():3077-3096. PubMed ID: 35330878
[TBL] [Abstract][Full Text] [Related]
8. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
Jiang H; Guo W; Yuan S; Song L
Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the role of QPCTL in glioma progression and cancer immunotherapy.
Liu Y; Lu S; Sun Y; Wang F; Yu S; Chen X; Wu LL; Yang H; Shi Y; Zhao K
Front Immunol; 2023; 14():1166377. PubMed ID: 37063864
[TBL] [Abstract][Full Text] [Related]
10. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
11. Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma.
Hou L; Zhou H; Wang Y; Liu J; Zhang D; Li Y; Xue X
Dis Markers; 2022; 2022():2091791. PubMed ID: 35783014
[TBL] [Abstract][Full Text] [Related]
12. Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase Family: Novel Prognostic Biomarkers and Tumor Microenvironment Regulators for Lower-Grade Glioma.
Gong S; Wu C; Köhler F; Meixensberger J; Schopow N; Kallendrusch S
Front Cell Neurosci; 2022; 16():838548. PubMed ID: 35250490
[TBL] [Abstract][Full Text] [Related]
13. Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma.
Yang B; Zhao Y; Wang L; Zhao Y; Wei L; Chen D; Chen Z
Front Oncol; 2020; 10():1695. PubMed ID: 33014843
[TBL] [Abstract][Full Text] [Related]
14. Serpin family H member 1 and its related collagen gene network are the potential prognostic biomarkers and anticancer targets for glioma.
Wang Q; Wang Z
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23541. PubMed ID: 37712121
[TBL] [Abstract][Full Text] [Related]
15. Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.
Zhou Q; Zhou J; Fan J
Front Oncol; 2021; 11():638803. PubMed ID: 34094918
[TBL] [Abstract][Full Text] [Related]
16. CENPA acts as a prognostic factor that relates to immune infiltrates in gliomas.
Wang B; Wei W; Long S; Wang L; Yang B; Wu D; Li Z; Li Z; Arshad M; Li X; Chen J
Front Neurol; 2022; 13():1015221. PubMed ID: 36341103
[TBL] [Abstract][Full Text] [Related]
17. High expression of PCOLCE gene indicate poor prognosis in patients and are associated with immune infiltration in glioma.
Guo Q; Gao X; Li J; Liu Y; Liu J; Yang H; Cui M; Zhang M; Duan L; Ma X
Sci Rep; 2023 Mar; 13(1):3820. PubMed ID: 36882457
[TBL] [Abstract][Full Text] [Related]
18. Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma.
Shan E; Cao YN; Zhang Y; Chen W; Ren X; Zhu S; Xi X; Mu S; Ma M; Zhi T; Li X
BMC Cancer; 2023 Sep; 23(1):846. PubMed ID: 37697240
[TBL] [Abstract][Full Text] [Related]
19. Overexpressing PLOD family genes predict poor prognosis in gastric cancer.
Li SS; Lian YF; Huang YL; Huang YH; Xiao J
J Cancer; 2020; 11(1):121-131. PubMed ID: 31892979
[TBL] [Abstract][Full Text] [Related]
20. Identification of genes related to low-grade glioma progression and prognosis based on integrated transcriptome analysis.
Jiang Y; He J; Guo Y; Tao H; Pu F; Li Y
J Cell Biochem; 2020 Jun; 121(5-6):3099-3111. PubMed ID: 31886582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]